Picture of Immuno-Biological Laboratories logo

4570 — Immuno-Biological Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapFalling Star

Table: Immuno Biological Lab - 9-MTH group results

Feb 2 (Reuters)- 
             Immuno Biological Laboratories Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            548 mln             554 mln          850 mln   
                 (-1.2 pct)          (+23.8 pct)      (+7.0 pct)  
  Operating        10 mln              18 mln           90 mln    
                 (-43.0 pct)                          (+54.2 pct) 
  Recurring        25 mln            loss 67 mln        90 mln    
  Net              20 mln            loss 76 mln        80 mln    
  EPS             2.21 yen          loss 8.20 yen      8.58 yen   
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Immuno Biological Laboratories Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T

Recent news on Immuno-Biological Laboratories

See all news